ArticleOpen forum infectious diseases2023

Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients.

Santosh Dhakal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.